May substantia nigra volume asymmetry be an indicator of motor asymmetry in Parkinson’s disease? A retrospective analysis
Objective: We investigated whether smaller substantia nigra is associated with worse parkinsonism on the corresponding contralateral side. Background: Degeneration of dopaminergic cells and morphologic changes…Functional connectivity alterations in Parkinson’s disease patients with impulsive control disorders
Objective: The aim of this study was to investigate cognitive functions and functional connectivity in PD according to the presence of ICDs. Background: The prevalence…Predicting incident impulse control disorder behaviour in Parkinson’s disease patients using a clinical-genetic model
Objective: Our aims were to estimate ICD heritability and to predict incident ICD behaviour by a candidate genetic multivariable panel in PD patients. Background: Impulse…Efficacy and safety of tetrabenazine in hyperkinetic movements disorders- An observational study
Objective: To assess the efficacy and side-effects of TBZ in Huntington disease (HD), vascular chorea, tics, dystonia, oromandibular dyskinesia and other tardive syndromes (TS). Background:…Progressive atrophy of parahippocampal gyrus correlates with Hoehn & Yahr stages of Parkinson’s disease: A voxel based morphometric study
Objective: To determine the gray matter (GM) changes in different clinical stages of Parkinson's disease (PD) using Voxel Based Morphometry (VBM). Background: PD is a…Substantia nigra hyperechogenicity in Parkinson´s disease motor phenotypes
Objective: To evaluate substantia nigra hyperechogenicity (SN+) with transcranial sonography (TCS) in different PD motor subtypes. Background: Parkinson´s disease (PD) patients display a range of…Brain mechanisms underlying visual processing in Parkinson’s disease
Objective: We used fMRI and a visual cognitive task to study brain mechanisms underlying visual processing at different cognitive loads in patients with PD and…Evaluating quantitative EEG (QEEG) measures to differentiate between Parkinson’s disease (PD) patients and healthy individuals
Objective: To evaluate QEEG measures for classification of Parkinson's disease(PD) patients and healthy individuals, and eventually develop a pre-clinical composite biomarker to identify patients with…Does dopamine affect the selection of stepping actions in PD?
Objective: To compare the selection of stepping actions during a probabilistic reaction time task in the ON state with the OFF state in people with…The patient’s perspective: The effect of dopamine on Parkinson symptoms
Objective: To investigate the correlation between patient-based vs. clinician-based L-Dopa effects on PD symptoms in tremor-dominant patients. Background: Medication adjustments are often solely based on…
- 1
- 2
- 3
- …
- 207
- Next Page »
